| CAS ID: | 141758-74-9 |
| Molecular Formula: | C184H282N50O60S |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Peptide |
| Natural Product: | No |
| Other Names: | BYDUREON BCISE | AC2993A | AC002993 | EXENATIDE | BYDUREON PEN | AC-2993 | BYETTA | Exenatide synthetic | BYDUREON |
| Analysis: | N/A |
Reference Record 1
Reference Record 2
| PubMed ID | 27831640 | Target ID | |
| Uniprot ID | Name | ||
| Model | rat | Fibrosis Disease | Pancreatic fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT02251431 | Disease | Renal fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | September 29, 2014 | Last Verified | August 9, 2018 |
| Sponsor | Baylor Research Institute | ||
| PubChem: | 45588096 |
| ChEMBL: | CHEMBL414357 |